Alnylam Pharmaceuticals
ALNY
#543
Rank
C$60.94 B
Marketcap
C$461.27
Share price
0.03%
Change (1 day)
14.16%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company